1. Home
  2. MCBS vs EMBC Comparison

MCBS vs EMBC Comparison

Compare MCBS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCBS
  • EMBC
  • Stock Information
  • Founded
  • MCBS 2006
  • EMBC 1924
  • Country
  • MCBS United States
  • EMBC United States
  • Employees
  • MCBS N/A
  • EMBC N/A
  • Industry
  • MCBS Major Banks
  • EMBC Medical/Dental Instruments
  • Sector
  • MCBS Finance
  • EMBC Health Care
  • Exchange
  • MCBS Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • MCBS 739.2M
  • EMBC 726.8M
  • IPO Year
  • MCBS 2019
  • EMBC N/A
  • Fundamental
  • Price
  • MCBS $26.90
  • EMBC $9.96
  • Analyst Decision
  • MCBS Hold
  • EMBC Buy
  • Analyst Count
  • MCBS 1
  • EMBC 2
  • Target Price
  • MCBS $34.00
  • EMBC $19.00
  • AVG Volume (30 Days)
  • MCBS 38.1K
  • EMBC 526.4K
  • Earning Date
  • MCBS 07-18-2025
  • EMBC 08-08-2025
  • Dividend Yield
  • MCBS 3.33%
  • EMBC 5.91%
  • EPS Growth
  • MCBS 20.64
  • EMBC N/A
  • EPS
  • MCBS 2.57
  • EMBC 0.89
  • Revenue
  • MCBS $145,158,000.00
  • EMBC $1,079,500,000.00
  • Revenue This Year
  • MCBS $18.90
  • EMBC N/A
  • Revenue Next Year
  • MCBS $30.18
  • EMBC N/A
  • P/E Ratio
  • MCBS $10.74
  • EMBC $11.39
  • Revenue Growth
  • MCBS 14.81
  • EMBC N/A
  • 52 Week Low
  • MCBS $24.24
  • EMBC $9.20
  • 52 Week High
  • MCBS $36.15
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • MCBS 33.94
  • EMBC 43.81
  • Support Level
  • MCBS $28.82
  • EMBC $9.68
  • Resistance Level
  • MCBS $30.06
  • EMBC $11.79
  • Average True Range (ATR)
  • MCBS 0.91
  • EMBC 0.51
  • MACD
  • MCBS -0.35
  • EMBC -0.05
  • Stochastic Oscillator
  • MCBS 3.70
  • EMBC 22.12

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: